<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: January 26, 1999
(Date of earliest event reported)
AMGEN INC.
(exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware Commission File: 95-3540776
(State or other jurisdiction 000-12477 (I.R.S. Employer Identification No.)
of incorporation or
organization)
</TABLE>
One Amgen Center Drive
Thousand Oaks, California 91320-1789
(Address of principal executive offices, including zip code)
(805) 447-1000
(Registrant's telephone number, including area code)
================================================================================
<PAGE>
ITEM 5. OTHER EVENTS
Stock Split
On January 26, 1999, the Board of Directors of Amgen Inc. (the
"Company") declared a 2-for-1 stock split on the Company's common stock, par
value $.0001 per share (the "Common Shares"), to be effected by means of a stock
dividend. The stock split will entitle each stockholder of record on February
12, 1999 (the "Record Date") to receive one additional Common Share for each
Common Share owned of record.
Before the stock split, the Rights Agreement, dated as of
February 18, 1997 between the Company and American Stock Transfer and Trust
Company (the "Rights Agreement") provided for one right to purchase one-one
thousandth (1/1000) of a share of Series A Junior Participating Preferred Stock
at $225.00 for each Common Share (the "Right"). Pursuant to Section 11.15 of
the Rights Agreement, after the stock split, each Common Share outstanding shall
have attached to it one-half (1/2) of a Right representing the right to purchase
one-two thousandth (1/2000) of a share of Series A Junior Participating
Preferred Stock at $112.50 (subject to possible future adjustment as provided in
the Rights Agreement).
As soon as practicable after the Record Date, the stockholders of
record on the Record Date will be sent a share certificate representing the
additional Common Shares to which they are entitled. The Common Shares will
begin trading on a split-adjusted basis on the Nasdaq National Market on
March 1, 1999.
This filing constitutes notice of the foregoing to the holders of
securities of the Company, including the Rights, for purposes of the Rights
Agreement and no other notice will be given.
Amendment to Registration Statement
Rule 416(a) provides that if a registration statement purports to register
securities offered pursuant to terms which provide for a change in the amount of
securities being offered or issued to prevent dilution resulting from stock
splits, such registration statement shall be deemed to cover the additional
securities to be offered as a result of any such stock split. Pursuant to Rule
416(a) the Company is hereby amending its registration statement No. 333-53929
to include the language set forth in Exhibit 99.1
2
<PAGE>
ITEM 7. FINANCIAL STATEMENT AND EXHIBITS.
Exhibit
No. Description
- ------- -----------
99.1 Amendment to Registration Statement No. 333-53929.
3
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
AMGEN INC.
Date: February 1, 1999 By /s/ George A. Vandeman
-------------------------------------
Name: George A. Vandeman
Title: Senior Vice President, Corporate
Development, General Counsel
and Secretary
4
<PAGE>
Exhibit 99.1
Pursuant to Rule 416(a), the number of shares being registered shall be
adjusted to include any additional shares which may become issuable as a result
of stock splits, stock dividends or similar transactions in accordance with the
adjustment provisions that govern the securities registered hereunder.
